NL-OMON26054尚未招募不适用
Efficacy and pharmacokinetics of a switch from a regimen consisting of emtricitabine, nevirapine and tenofovir to rilpivirine, emtricitabine and tenofovir in virologically suppressed HIV-1 infected patients.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- Erasmus MC
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Able to take medication with a 500 kcal meal;
- •2. Treated with NVP, FTC, TDF for at least the last 9 months;
排除标准
- •1. Use of proton pump inhibitors;
- •2. Use of H2-antagonists.
研究者
相似试验
进行中（未招募）
不适用
Efficacy and pharmacokinetics of a switch from a regimen consisting of emtricitabine, nevirapine and tenofovir to rilpivirine, emtricitabine and tenofovir in virologically suppressed HIV-1 infected patients.EUCTR2012-001142-18-NLErasmus MC50
已完成
1 期
Switching Study From Warfarin to RivaroxabanVenous ThrombosisNCT01507051Bayer96
已完成
不适用
Study of effectiveness of the switch from Gn-RH agonist to degarelix for patients with prostate cancer as a second-line hormone therapyProstate cancerJPRN-UMIN000015300Yokohama City University Hospital100
进行中（未招募）
不适用
Farmacokinetische evaluatie van de overschakeling van intraveneuze naar enterale toediening van moxifloxacine bij Intensieve Zorgen patiënteEUCTR2006-006334-18-BEniversity Hospital Gent
已完成
3 期
A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisRheumatoid ArthritisNCT04230213Pfizer455